Medi Siddh Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-06-2024
- Paid Up Capital ₹ 4.30 M
as on 16-06-2024
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.58 M
as on 16-06-2024
- Revenue -26.73%
(FY 2022)
- Profit -190.98%
(FY 2022)
- Ebitda -156.52%
(FY 2022)
- Net Worth -14.19%
(FY 2022)
- Total Assets 14.67%
(FY 2022)
About Medi Siddh Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.30 M.
The company currently has active open charges totaling ₹1.58 M.
Rajkumar Sundararajan, Subbulakshmi Sundrarajan, and Alaguraj serve as directors at the Company.
- CIN/LLPIN
U33112TN1989PTC017917
- Company No.
017917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 1989
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kovilpatti, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medi Siddh Pharma Private Limited offer?
Medi Siddh Pharma Private Limited offers a wide range of products and services, including Ayurvedic Digestive Medicine, Digestive Herbal Capsule & Tablet, Herbal Piles Medicine, Herbal Piles Capsules and Tablets, Liver Supplement, Ayurvedic Liver Tablets Capsules, Turmeric Products, Turmeric Curcumin, Homeopathic Drugs, Homoeopathic Syrup.
Who are the key members and board of directors at Medi Siddh Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Sundararajan  | Director | 18-Dec-2017 | Current |
| Subbulakshmi Sundrarajan | Director | 14-Dec-2015 | Current |
| Alaguraj | Director | 07-Aug-2012 | Current |
Financial Performance of Medi Siddh Pharma.
Medi Siddh Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.73% decrease. The company also saw a substantial fall in profitability, with a 190.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Siddh Pharma?
In 2022, Medi Siddh Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Emd Systems Software Private LimitedActive 15 years 1 monthRajkumar Sundararajan, Subbulakshmi Sundrarajan and 1 more are mutual person
- Gb Recycle India Private LimitedActive 3 years 4 months
Subbulakshmi Sundrarajan and Alaguraj are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jun 2021 | ₹1.47 M | Open |
Bank Of Madurai Ltd. Creation Date: 08 Jun 1990 | ₹0.11 M | Open |
How Many Employees Work at Medi Siddh Pharma?
Medi Siddh Pharma has a workforce of 45 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi Siddh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Siddh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
